Biostatistician Profile - Michael E. Scheurer, Ph.D., M.P.H.
Division of Biostatistics, Dan L. Duncan Cancer Center
Department of Pediatrics, Section of Hematology/Oncology
1997 - B.S., Biological Sciences/Anthropology, University of Alabama, Tuscaloosa, AL
1999 - M.P.H., Epidemiology, University of Alabama at Birmingham, Birmingham, AL
2004 - Ph.D., Epidemiology, University of Texas School of Public Health at Houston, Houston, TX
2006 - Postdoctoral Fellowship, Molecular Epidemiology, University of Texas M. D. Anderson Cancer
Center, Houston, TX
Honors and Awards
2005 - Delta Omega Honorary Society in Public Health, Alpha Iota Chapter, The University of Texas
School of Public Health, Houston, TX
2006 - AACR-Eli Lilly Scholar-in-Training Award
2006 - Society for Neuro-Oncology Award for Excellence in Epidemiology
1999-present - American Public Health Association, member, Epidemiology Section,
HIV/AIDS Section, Biostatistics Section
2003-present - International Papillomavirus Society, member
2004-present - American Association for Cancer Research, member, Molecular Epidemiology
2004-present - American Statistical Association, member
2005-present - American Society of Preventive Oncology, member, Molecular Epidemiology Study
Group, Young Investigators Study Group
2006-present - Society for Epidemiologic Research
2006-present - Society for Neuro-Oncology
Description of Research
My research focuses on viruses and immune function as risk factors for cancer development and progression. Specifically, I have a research project examining Human papillomavirus-associated cervical cancer, and I am building a program looking at Human cytomegalovirus and host immune function in relation to brain tumors. I also have an interest in determining the risk factors for pediatric tumors, in particular childhood brain tumors.
My laboratory looks for novel ways to identify and catalog molecular markers of viral infection, including host-virus interactions, as risk factors for the development of cancer.
Publications (in chronological order)
Hoelscher DM, Day RS, Lee ES, Frankowski R, Kelder SH, Ward JL, Scheurer ME. Measuring the Prevalence of Childhood Overweight in Texas School Children. Amer J Pub Health, 94(6):1002-8, 2004 Jun.
Scheurer ME, Tortolero-Luna G, Guillaud M, Follen M, Chen Z, Dillon LM, Adler-Storthz K. Correlation of HPV 16 and HPV 18 E7 mRNA levels with degree of cervical dysplasia. Cancer Epi Biomarker Prevent, 14(8): 1948-52, 2005 Aug.
Scheurer ME, Tortolero-Luna G, Adler-Storthz K. Human Papillomavirus Infections: Biology, Epidemiology, and Prevention. Int J Gynecologic Cancers, 15(5): 727-46, 2005 Sept/Oct.
Scheurer ME, Dillon LM, Chen Z, Follen M, Adler-Storthz K. Absolute quantitative real-time polymerase chain reaction for the measurement of human papillomavirus E7 mRNA in cervical cytobrush specimens. Infect Agents Cancer 2:8, 2007 Apr.
Scheurer ME, Guillaud M, Tortolero-Luna G, McAulay C, Follen M, Adler-Storthz K. Human papillomavirus-related cellular changes measured by cytometric analysis of DNA ploidy and chromatin texture. Cytometry B Clin Cytom. 72(5):324-31, 2007 Sept.
Scheurer ME; El-Zein RA; Bondy ML; Harkins L; Cobbs CS. RE: “Lack of association of herpesviruses with brain tumors”. J Neurovirol 13(1):85, 2007.
Bondy ML, El-Zein RA, Scheurer ME. Epidemiology of Brain Tumors. In: DeMonte et al (eds). Tumors of the Brain and Spine, Vol. VI, M. D. Anderson Cancer Care Series. Springer: New York, 1-22, 2007.
Scheurer ME, Guillaud M, Tortolero-Luna G, Follen M, Adler-Storthz K. Epidemiologic modeling of cervical dysplasia with molecular and cytopathological markers. Gynecol Oncol 107(1S):S163-S169, 2007 Oct.
Pham B, Earle N, Rabel K, Follen M, Scheurer ME. Maximizing the diversity of participants in a phase II clinical trial which uses optical technologies to detect cervical neoplasia. Gynecol Oncol 107(1S):S208-S214, 2007 Oct.
Scheurer ME, Etzel CJ, Liu M, El-Zein R, Airewele GE, Aldape KD, Weinberg JS, Yung WKA, Bondy ML. Aggregation of Cancer in First-degree Relatives of Patients with Glioma. Cancer Epidemiol Biomarker Prevent. 16(11):2491-5, 2007 Nov.